Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there. Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label warfarin. Show all posts
Showing posts with label warfarin. Show all posts

Thursday, October 1, 2026

What Vitamins Are Good for Gut Health?

 Your competent? doctor and dietician have already figured out the EXACT PROTOCOL FOR OPTIMAL GUT MICROBIOME, right?

Oh NO; NOTHING was done; PURE INCOMPETENNCE!

And you haven't gotten them fired yet?

What Vitamins Are Good for Gut Health?

Your gut supports your overall health, but it needs support from you via a whole-food diet to do so. Here’s how to feed your gut.

Improved gut health can boost your overall wellbeing, so are you listening to your gut? Eating nutrient-dense whole foods that contain gut-supporting vitamins, like vitamins D, A, C, B, and K can improve your gut health. The relationship actually runs both ways: certain vitamins feed your gut, and your gut bacteria provide your body with enzymes necessary to regulate your health. Additionally, short-chain fatty acids — compounds your gut bacteria make when they break down carbs and dietary fiber — are produced in your gut during digestion. 

Simply put, research shows this process in your gut helps control inflammation, regulate your immune system, reduce obesity, and more. The best news? Most of these vitamins your gut needs to carry out these processes probably already come from the foods you are eating. Here, registered dietitians Alison Swiggard, MS, RD, LDN, founder of In Good Company Nutrition, and Ilana Schachter, RDN, of Consumer Health Digest, weigh in on exactly what vitamins are good for gut health, plus how they support your overall wellbeing.

TL;DR

Nutrients help maintain the gut lining, feed microbial diversity, and support immunity. But you might wonder, what vitamins are good for gut health? The vitamins most linked to gut health are D, A, C, B, and K. While your daily dose of these vitamins typically comes from a varied diet, there are some, like vitamin D, that many people fall short on. 

Key Takeaways

  • The most-studied vitamins for gut health are D, A, C, K, and the B vitamins.
  • Vitamin D stands out for helping maintain the gut lining and a balanced microbiome, though intake of this vitamin is the most common shortfall from diet alone.
  • Intake of these nutrients isn’t the only thing supporting gut health — your gut bacteria synthesize some of your B vitamins and vitamin K, which provides additional benefits.
  • When you think of vitamins for gut health, you don’t necessarily have to add a supplement to your diet. Instead, a varied whole-food diet covers most of your needs. 
  • What the Research Says About Vitamins for Gut Health

Your gut — which includes the mouth, the esophagus, the stomach, the small and large intestines and the anus — breaks down the food you eat, and helps your body absorb necessary nutrients from your diet. A healthy gut microbiome (made up of thousands of species of bacteria, viruses, fungi, and parasites) is one of the keys to overall health, and may even support longevity, according to research. One 2022 review published in Gut connected the gut microbiome to a range of health conditions, including obesity, type 2 diabetes, inflammatory bowel disease, and certain cancers.

We’re becoming increasingly aware of just how beneficial vitamins are for gut health, and the role gut health plays in our longevity. Dietary fiber is important for feeding the bacteria in the gut, which supports biological functions in the body as well as your gastrointestinal tract.

“When it comes to supplements for gut health, the goal should not be to take the most. It should be to take what your body actually needs”

While emerging research around how much and what types of supplements can shift the gut microbiome is helping us understand more about how important our gut health really is, there’s still plenty of confusion on what’s truly beneficial.

“When it comes to supplements for gut health, the goal should not be to take the most. It should be to take what your body actually needs,” says Swiggard.

How Vitamins Support Your Gut (and How Your Gut Returns the Favor)

Vitamins help support the body systems that keep the gut functioning well, including the immune system, intestinal lining, energy production, and tissue repair, Swiggard explains. But the two also work together: Gut health also affects vitamin status. For example, the gut microbiome plays a role in producing or metabolizing some nutrients, creating a self-sufficient system to keep the body healthy, and on the flip-side, certain GI conditions can impair absorption.

Some vitamins reinforce the gut lining and the junctions between cells (vitamin D), support the mucosal immune system (vitamins A and D), and help feed a more diverse microbiome and its short-chain fatty acids (vitamins C and B2).

The Key Vitamins for Gut Health

“A food-first approach remains the foundation of gut health, emphasizing fiber-rich foods such as fruits, vegetables, legumes, whole grains, nuts, seeds, and fermented foods when tolerated,” says Schachter.

These are the nutrients that play a role in gut-related functions.

Vitamin D

When it comes to vitamin D and gut health, the nutrient is involved in immune regulation, according to Schachter. While low vitamin D levels in the gut are linked to higher instances of IBD, the nutrient may help support patients with IBD, such as reducing the risk of surgery for those with Crohn’s disease.

The current Recommended Dietary Allowance (RDA) of vitamin D is 600 International Units (IUs) for those age 70 and under. Most foods don’t contain much vitamin D unless it’s added, such as in fortified cereal. Other dietary sources of vitamin D include fatty fish, like salmon or mackerel, and eggs. Typically, your body makes vitamin D from direct sunlight on the skin, so the amount you get can vary depending on the time of year or how much sun exposure you get, affecting your vitamin D levels. This is where supplementation comes in, if your healthcare provider deems it necessary.  

Sometimes, your body doesn’t properly absorb vitamin D, which can happen in those with inflammatory bowel diseases, like Crohn’s disease or ulcerative colitis. These gut conditions can prevent proper nutrient absorption. 

Vitamin A

Vitamin A supports tissue integrity and immune function, Swiggard says. Vitamin A supports the gut’s mucosal lining — the moist, protective barrier that lines your gut wall and helps block harmful microbes — assisting in keeping us healthy and boosting our immune system, research shows.

The RDA of vitamin A is 900 micrograms (mcg) for men and 700 mcg for women, but more is required during pregnancy (770 mcg) and for those who are breastfeeding (1,300 mcg). Beta-carotene in colorful produce, like carrots, spinach, and sweet potatoes, is converted into vitamin A in the gut. You can also find vitamin A in foods like liver, eggs, and dairy.

As long as you eat a variety of fresh foods, there’s usually no need for supplementation. Certain health conditions, like cystic fibrosis or celiac disease may require vitamin A supplements, but it’s best to check with your doctor.

Vitamin C

Vitamin C may help beneficial gut bacteria flourish. A small study published in Future Microbiology found that vitamin C supplementation increased levels of the gut bacteria Bifidobacterium — a group linked to immune support — by roughly threefold. Additionally, research published in Gut Microbes found that vitamin C supplementation increased the diversity of gut microbes and the amount of short-chain fatty acids. Recent research published in Scientific Reports found that short-chain fatty acids can support the lining of the gut and even boost the gut-brain connection.

The RDA of vitamin C, also known as ascorbic acid, for adults is 90 mg for men and 75 mg for women. Citrus fruits, peppers, berries, broccoli, and baked potatoes are all great dietary sources of vitamin C. 

B Vitamins

There are eight B vitamins that make up the B complex. B vitamins, such as folate and B12, support normal cell turnover and energy metabolism, Schachter says. Research published in mSystems confirms gut bacteria have the potential to produce all eight B vitamins. Additionally, B vitamins are among the vitamins for digestion that matter most, especially when absorption is impaired, according to Swiggard.

The recommended dietary allowance of B vitamins is different for each. Men need 1.2 mg and women need 1.1 mg daily of thiamin (B1), a B vitamin that helps provide energy. Adults need 400 mcg daily of folate, or B9, which helps keep your red blood cells healthy and is often most associated with healthy pregnancy.  

Dietary sources of B vitamins include whole grains, legumes, eggs, leafy greens, and animal proteins.

Vitamin K

Vitamin K is connected to your gut bacteria because some forms of this nutrient are actually produced by microbes in the colon, Swiggard says. This vitamin helps to support your gut-whole body connection. Preliminary research published in Frontiers in Immunology suggests this vitamin is useful in supporting intestinal health and may even help prevent diseases like inflammatory bowel disease and colorectal cancer.

The daily intake recommendation for adult men is 120 mcg and 90 mcg for adult women. Add leafy greens, vegetable oils, or fermented foods, like sauerkraut or kefir, to your plate to help with intake.

Yes, you can have vitamin K while taking warfarin, but you must keep your daily intake consistent

How to Get Enough of These Vitamins for Gut Health

Filling your plate with varied whole foods will help to ensure you are getting your fill of all the gut-healthy vitamins — there’s no need to focus your meals around one vitamin. And, be sure to pair fat-soluble vitamins (A, D, and K) with dietary fat to help with absorption. For example, you can add some healthy fats, like olive oil, avocado, or nuts to your meal.

Friday, May 29, 2026

Scientists Develop Enhanced Vitamin K Compound That May Help Repair Brain Damage

 

Ask your competent? doctor how to eat healthy if on warfarin and can't consume Vitamin K foods.  You do want good cognition and no inflammation, right? That requires a diet protocol and I bet your incompetent doctor doesn't have one for you! Is your doctor also FUCKING INCOMPETENT  in not getting human testing going?

Scientists Develop Enhanced Vitamin K Compound That May Help Repair Brain Damage

Thursday, December 11, 2025

Asundexian Reduces Risk of Future Ischemic Stroke as Secondary Prevention

 What is your doctor's guaranteed protocol to prevent the next stroke? Oh, just warfarin(rat poison) and then aspirin! Those are just guidelines; NOT PROTOCOLS!

Of course, your competent? doctor knew about this earlier this year, right!
  • Asundexian (2 posts to April 2025)
  • Asundexian Reduces Risk of Future Ischemic Stroke as Secondary Prevention

     

    Key Takeaways

     Asundexian reduced ischemic stroke risk without increasing major bleeding in patients with prior non-cardioembolic ischemic strokes or high-risk transient ischemic attacks. Stroke is a leading global cause of death, with high recurrence rates and severe consequences, necessitating new treatment options. Asundexian shows promise in reducing ischemic stroke risk without increasing major bleeding, offering hope for secondary stroke prevention. In the phase 3 OCEANIC-STROKE study (NCT05686070), asundexian (Bayer), an investigational, once-daily, oral factor XIa (FXIa) inhibitor, reduced the risk of ischemic stroke compared with placebo in combination with antiplatelet therapy. The effects were seen in a cohort of patients who previously experienced a non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. Ischemic stroke could lead to debilitating impacts and a recurrent stroke in the future. | Image Credit: © samunella - stock.adobe.com Critically, there was no increase in the risk of major bleeding as defined by the International Society on Thrombosis and Haemostasis in patients treated with asundexian compared with placebo. The results were announced in a news release from Bayer, with future data expected to be presented at an upcoming scientific meeting, according to the authors. “As clinicians, we see every day how devastating a recurrent stroke can be for patients and their families. Even with currently available therapies, the risk of another stroke remains high, and each recurrence can have profound consequences,” Mike Sharma, MD, a principal investigator of the OCEANIC-STROKE study and director of the stroke program at Hamilton Health Services, said in the news release. Stroke constitutes a major burden globally; it’s the second leading cause of death across the world, and each year, 12 million individuals experience a stroke. After a stroke, the resulting disability is often significant. Patients could face paralysis on one side of their body, difficulties speaking or finding which words to say, memory loss, and vision problems, among others. Beyond the physical impacts after a stroke, many patients ultimately experience a recurrent stroke. There is a concerning increase in stroke incidence among young and middle-aged individuals, necessitating new treatment capabilities. “The topline results from OCEANIC-STROKE indicate that asundexian may become a new treatment option to reduce this risk—representing a potential major step forward in secondary stroke prevention,” Sharma continued1 

    Asundexian's Background, Safety, and Tolerability

     OCEANIC-STROKE has enrolled over 12,000 patients since its initiation. Results from the multicenter, international, randomized, placebo-controlled, double-blind, parallel-group, event-driven study could further bolster asundexian’s regulatory status. In 2022, the FDA granted the agent fast track designation based on positive results from a phase 2 (NCT04304508) study. Future clinical trial research could mean further regulatory movement for asundexian based on FDA decisions.1,5Asundexian is a small molecule that binds and inhibits the activity of FXIa. The agent selectively inhibits the intrinsic coagulation pathway, thereby preventing thrombosis without hindering clotting responses that initiate after an injury. Although FXIa only has a small role in the formation of a seal at the site of a vessel injury, it is thought to contribute to the formation of pathological thrombus growth and vessel blockage. Asundexian achieves reductions in thrombus formation without major increases in rates of significant bleeding. In phase 1 studies, asundexian appeared to be well-tolerated. Common treatment-emergent adverse events included headache and nasopharyngitis, but all events were considered mild. Furthermore, all events were considered mild, with no clinically significant examinations or procedures observed in any patients. The current phase 3 results did not fully reveal safety indications, but the lack of increase in risk of major bleeding was a major demonstration of tolerability across the population.


    Tuesday, August 5, 2025

    Stroke symptoms(really they meant warning signs) can appear a decade before

     None of these applied to me at all. Had my stroke at age 50 from something on a whitewater canoe trip down the Dog River in Ontario dropping 1150 feet in 23 miles. Some hairy whitewater in fully loaded solo canoes. Swam a few of the rapids. Tore the plaque lining my right carotid artery, clotted and let go when I got home. My doctors did nothing to reduce my future risk of more plaque tearing. I don't consider the warfarin use an effective enough prevention since that doesn't address plaque tearing at all.

    Stroke symptoms can appear a decade before

    Early warning signs may show up long before a stroke strikes, offering a crucial window for prevention. New research suggests cognitive changes and daily task struggles can signal risk years in advance.

    Rapid mental decline predicts stroke

    A long-term cohort of 5 810 middle-aged adults in the Whitehall II study had reasoning, memory, vocabulary and verbal fluency assessed three times over 10 years¹. Researchers found that those in the highest midlife stroke-risk quartile experienced accelerated decline in global cognition up to ten years before their first stroke.

    Daily tasks become challenging

    Up to three years before a stroke, participants began reporting greater difficulty with routine activities—dressing, showering and meal preparation all became markedly harder². Such early functional impairments may be overlooked, but they offer a clear snapshot of rising stroke risk.

    Women at higher risk

    Globally, women account for approximately 56 % of all stroke cases³, highlighting a gender disparity in stroke vulnerability. Carriers of the APOE ε4 allele—best known for its association with Alzheimer’s disease—may also face elevated stroke risk⁴.

    Did you know? Women’s lifetime risk of stroke is roughly 1 in 5, compared with about 1 in 6 for men³.

    Prevention through lifestyle changes

    Public health bodies emphasise that around 90 % of strokes are attributable to modifiable risk factors⁵. Experts recommend key lifestyle changes:

    • Engage in at least 150 minutes of moderate exercise per week (e.g. brisk walking)

    • Follow a diet rich in fruits, vegetables and whole grains, limiting salt intake

    • Monitor and manage blood pressure, cholesterol and blood sugar with regular checks and medical advice

    By spotting subtle warning signs and adopting these habits early, individuals can significantly reduce their stroke risk and protect long-term brain health.

    Thursday, July 17, 2025

    The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic Perspectives

     Pretty useless, nothing on how to test for this and NOTHING ON AMOUNTS!

    The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic Perspectives


    Affiliations 

    Abstract

    This review evaluates the role of vitamins in neurodegeneration. 

    Low levels of B vitamins have been associated with cognitive decline. B vitamins may help inhibit amyloid plaque aggregation. 

    Vitamin D deficiency has been linked to an increased risk of cognitive impairment, correlating with Alzheimer's pathology. 

    Vitamin E may help delay Alzheimer's disease progression and support functional abilities. 

    In Parkinson's disease, vitamin D shows promise in reducing dopaminergic neuron loss and improving motor and cognitive outcomes. 

    Vitamin C reduces oxidative stress and preserves neuronal integrity. 

    Vitamin K has gained attention for its role in cognitive health, with studies suggesting that higher levels may be linked to improved cognitive performance.(Not to be taken while on warfarin(rat poison)) In conclusion, a better understanding of the translational potential of these vitamins may inform preventive and therapeutic strategies for neurodegenerative diseases. Clinicians should consider vitamin supplementation for aging-related conditions. Further studies are needed to confirm its therapeutic potential and clarify underlying mechanisms in neurodegeneration.

    Keywords: Alzheimer's disease; cognitive impairment; neurodegeneration; neuroprotection; oxidative damage; vitamin supplementation.

    PubMed Disclaimer

    Similar articles


    References at link.

    Friday, January 31, 2025

    Low Vitamin K Intake Impairs Cognition, Neurogenesis, and Elevates Neuroinflammation in C57BL/6 Mice

     Ask your competent? doctor how to eat healthy if on warfarin and can't consume Vitamin K foods.  You do want good cognition and no inflammation, right? That requires a diet protocol and I bet your incompetent doctor doesn't have one for you! 

    When taking warfarin, it is crucial to avoid foods that can interact with the medication and affect its effectiveness. Here are some foods to avoid: 
    Foods High in Vitamin K: Green leafy vegetables (e.g., spinach, kale, broccoli, collard greens)
    • Liver
    • Brussels sprouts
    • Asparagus
    • Cauliflower
    Foods Containing Flavonoids: grapefruit juice, green tea, and cranberry juice. Other Foods: alcohol, black licorice, turmeric, avocado, and olive oil

    Low Vitamin K Intake Impairs Cognition, Neurogenesis, and Elevates Neuroinflammation in C57BL/6 Mice

    Tong Zheng
    , , , , , ,
    https://doi.org/10.1016/j.tjnut.2025.01.023
    Get rights and content

    Abstract

    Background

    In addition to its important roles in blood coagulation and bone formation, vitamin K (VK) contributes to brain function. Low dietary VK intake, which is common among older adults, is associated with age-related cognitive impairment.

    Objective

    To elucidate the biological mechanisms underlying VK’s effects on cognition, we investigated the effects of low VK (LVK) intake on cognition in C57BL/6 mice.

    Methods

    Male and female 9-month old C57BL/6 mice (n=60) were fed a LVK diet or a control diet for 6 months. Behavioral tests were performed on a subset of animals (n=26) at 15 months and brain tissues were collected for follow-up analyses.

    Results

    Menaquinone-4 (MK4), the predominant VK form in the brain, was significantly lower in LVK animals compared to controls (15.6±13.3 vs 189±186 pmol/g, respectively, p<0.01). LVK animals showed reduced recognition memory in the novel object test by spending a lower percentage of time exploring the novel object compared to controls (47.45%± 4.17 vs. 58.08%±3.03, p=0.04). They also spent a significantly longer time learning the task of locating the platform in the Morris water maze test. Within the hippocampal dentate gyrus, LVK animals had a significantly lower number of proliferating cells, and fewer newly generated immature neurons compared to control animals. Additionally, more activated microglia cells were identified in the LVK animals.

    Conclusion

    Our data indicate that LVK intake reduced MK4 levels in brain tissues and impaired learning- and memory-related cognitive function. This impairment may be related to the observed reduced hippocampal neurogenesis and elevated neural inflammation.

    Introduction

    Within the next decade, it is estimated that there will be more Americans over the age of 65 years than under the age of 18 years [1], and many of these older adults will develop age-related cognitive impairments [2]. Modifiable factors, such as nutrition, have been implicated as important modulators for cognition [3], [4]. Growing evidence has shown that low vitamin K may have a role in age-related cognitive decline [5]. Green leafy vegetables are the main source of phylloquinone (PK), the primary form of dietary vitamin K [6], [7]. Concerningly, most adults do not consume the recommended quantity of these foods, leading to inadequate phylloquinone intake, especially among older adults in the U.S. [8]. Mostly known for its role in blood coagulation, phylloquinone is believed to also have important functions in the nervous system [9], [10]. Through recent and novel stable isotope experiments in rodent models, it has been shown that manipulation of dietary vitamin K causes rapid changes to the concentration of menaquinone-4 (MK4), which is the predominant form of vitamin K in the brain [11]. We also now know that all dietary forms of vitamin K convert to MK4 [12].
    Observational data from the Rush Memory and Aging Project (MAP) demonstrated that higher postmortem brain levels of MK4 were associated with better cognitive function proximate to death. Further investigation of neuropathologically-defined outcomes also revealed that higher brain MK4 concentrations were associated with lower global dementia pathology, specifically fewer neurofibrillary tangles [13]. While these findings are encouraging, MK4 in the brain may simply be tracking healthy dietary patterns associated with higher vegetable intakes. Furthermore, the underlying biological mechanisms have yet to be elucidated. Thus, there is a critical need to establish the biological mechanism(s) underlying the cognition-protective effects of vitamin K in an animal model to overcome the limitations of observational data. Given that: 1) inflammation, which is closely associated with aging and neurodegeneration, impairs hippocampal neurogenesis; and 2) age-related cognitive decline is accompanied by reduced neurogenesis in the hippocampus, we propose that vitamin K’s protective effects on cognition and brain resilience may function through maintaining hippocampal neurogenesis and anti-inflammation.

    Access through your organization

    Friday, May 6, 2022

    Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

     The safety profiles of both are not that reassuring, our stroke medical professionals should be able to do better. This tyranny of low expectations  needs to stop. Accepting failure like this seems to be endemic to stroke; 'Hey, most persons survived, who gives a shit about their quality of life?'

    Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

    Originally publishedhttps://doi.org/10.1161/STROKEAHA.121.037541Stroke. 2022;53:728–738

    Abstract

    Background:

    A small randomized controlled trial suggested that dabigatran may be as effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to compare direct oral anticoagulants (DOACs) to warfarin in a real-world CVT cohort.

    Methods:

    This multicenter international retrospective study (United States, Europe, New Zealand) included consecutive patients with CVT treated with oral anticoagulation from January 2015 to December 2020. We abstracted demographics and CVT risk factors, hypercoagulable labs, baseline imaging data, and clinical and radiological outcomes from medical records. We used adjusted inverse probability of treatment weighted Cox-regression models to compare recurrent cerebral or systemic venous thrombosis, death, and major hemorrhage in patients treated with warfarin versus DOACs. We performed adjusted inverse probability of treatment weighted logistic regression to compare recanalization rates on follow-up imaging across the 2 treatments groups.

    Results:

    Among 1025 CVT patients across 27 centers, 845 patients met our inclusion criteria. Mean age was 44.8 years, 64.7% were women; 33.0% received DOAC only, 51.8% received warfarin only, and 15.1% received both treatments at different times. During a median follow-up of 345 (interquartile range, 140–720) days, there were 5.68 recurrent venous thrombosis, 3.77 major hemorrhages, and 1.84 deaths per 100 patient-years. Among 525 patients who met recanalization analysis inclusion criteria, 36.6% had complete, 48.2% had partial, and 15.2% had no recanalization. When compared with warfarin, DOAC treatment was associated with similar risk of recurrent venous thrombosis (aHR, 0.94 [95% CI, 0.51–1.73]; P=0.84), death (aHR, 0.78 [95% CI, 0.22–2.76]; P=0.70), and rate of partial/complete recanalization (aOR, 0.92 [95% CI, 0.48–1.73]; P=0.79), but a lower risk of major hemorrhage (aHR, 0.35 [95% CI, 0.15–0.82]; P=0.02).

    Conclusions:

    In patients with CVT, treatment with DOACs was associated with similar clinical and radiographic outcomes and favorable safety profile when compared with warfarin treatment. Our findings need confirmation by large prospective or randomized studies.

     

    Thursday, July 15, 2021

    Warfarin Treatment Is Associated to Increased Internal Carotid Artery Calcification

    You'll need your doctor to monitor this. In my case I was only on it for 2 months, later on they say the median duration was 1.6 years, so I guess I was ok.

    Warfarin Treatment Is Associated to Increased Internal Carotid Artery Calcification

     
    Krista Nuotio1,2*, Suvi M. Koskinen2,3, Laura Mäkitie1,2, Jarno Tuimala4, Petra Ijäs1,2, Hanna M. Heikkilä2, Jani Saksi2, Pirkka Vikatmaa5, Pia Sorto2, Sonja Kasari2, Ilari Paakkari6, Heli Silvennoinen3, Leena Valanne3, Mikko I. Mäyränpää7, Lauri Soinne1,2, Petri T. Kovanen8 and Perttu J. Lindsberg1,2
    • 1Neurology, Neurocenter, Helsinki University Hospital, Helsinki, Finland
    • 2Clinical Neurosciences, Clinicum, University of Helsinki, Helsinki, Finland
    • 3Medical Imaging Center, Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
    • 4Independent Researcher, Helsinki, Finland
    • 5Abdominal Center, Vascular Surgery, Helsinki University Hospital, Helsinki, Finland
    • 6Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
    • 7Pathology, Helsinki University and Helsinki University Hospital, Helsinki, Finland
    • 8Wihuri Research Institute, Biomedicum Helsinki 1, Helsinki, Finland

    Background: Long-term treatment with the vitamin K antagonist warfarin is widely used for the prevention of venous thrombosis and thromboembolism. However, vitamin K antagonists may promote arterial calcification, a phenomenon that has been previously studied in coronary and peripheral arteries, but not in extracranial carotid arteries. In this observational cohort study, we investigated whether warfarin treatment is associated with calcification of atherosclerotic carotid arteries.

    Methods: Overall, 500 consecutive patients underwent carotid endarterectomy, 82 of whom had received long-term warfarin therapy. The extent of calcification was assessed with preoperative computed tomography angiography, and both macroscopic morphological grading and microscopic histological examination of each excised carotid plaque were performed after carotid endarterectomy.

    Results: Compared with non-users, warfarin users had significantly more computed tomography angiography-detectable vascular calcification in the common carotid arteries (odds ratio 2.64, 95% confidence interval 1.51–4.63, P < 0.001) and even more calcification in the internal carotid arteries near the bifurcation (odds ratio 18.27, 95% confidence interval 2.53–2323, P < 0.001). Histological analysis revealed that the intramural calcified area in plaques from warfarin users was significantly larger than in plaques from non-users (95% confidence interval 3.36–13.56, P = 0.0018).

    Conclusions: Long-lasting warfarin anticoagulation associated with increased calcification of carotid atherosclerotic plaques, particularly in locations known to be the predilection sites of stroke-causing plaques. The clinical significance of this novel finding warrants further investigations.

    Introduction

    An atherosclerotic lesion in the internal carotid artery is a major cause of cerebral ischemic stroke. Although many elements of the underlying pathological processes of atherosclerosis, e.g., lipid accumulation and the inflammatory component, have been well-characterized in developing atherosclerotic lesions (1), the multifaceted roles of calcification in atherosclerotic lesions are still debated and under investigation (2–5).

    Atrial fibrillation (AF), the most common sustained arrhythmia (6) poses a significant risk for cerebral embolism, which is most effectively prevented by anticoagulants (7–9). Both warfarin and modern oral anticoagulants are available and neurologists are frequently deciding on anticoagulation on patients with AF, often with simultaneous large artery atherosclerosis.

    Warfarin has been claimed to have harmful effects on the arterial wall. Evidence from experimental animals has demonstrated that treatment with warfarin is linked to vascular calcification (10, 11), with similar findings from preliminary human studies (12–14). Human studies have suggested that exposure to warfarin may increase calcification in coronary arteries (15, 16), peripheral arteries (17), aorta (18), and aortic valve leaflets (19).

    However, there are only a few studies that have investigated the association of warfarin and vascular calcification in carotid arteries (20, 21), and none of them has studied vascular calcification in extracranial carotid arteries. Hence, the present clinical investigation was undertaken to evaluate the hypothesis that chronic warfarin use is associated with vascular calcification in atherosclerotic carotid artery disease. We examined the preoperative computed tomography angiography (CTA) results, macroscopic calcification of the dissected carotid specimens, and histopathology of the plaques to determine the potential presence of calcification, and the extent of different types of calcification. The results obtained in users and non-users of warfarin therapy were compared.